Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2014

01-02-2014 | Epidemiology

Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study

Authors: Elham Kharazmi, Tianhui Chen, Steven Narod, Kristina Sundquist, Kari Hemminki

Published in: Breast Cancer Research and Treatment | Issue 1/2014

Login to get access

Abstract

The objective of this nationwide prospective cohort study is to find out the risk of breast cancer (BC) in relatives of patients with multiple BCs by laterality and age at diagnosis of first BC. Having family history of single (HR 1.8; 95 % CI 1.8–1.9) or multiple (HR 2.7; 95 % CI 2.6–2.9) BC was associated with higher risk of BC. Those with an FDR with contralateral BC at any age had the highest risk of familial cancer except at age <40 in which those whose young FDR was affected by multiple ipsilateral BC had the highest risk (HR 9.7; 95 % CI 6.0–15.6). The familial risk of BC in these families decreased as the subject’s and FDRs’ age at diagnosis of first BC increased. The HR was still significantly increased (2.2) for old individuals (>60) having a FDR with contralateral BC at an advanced age (≥80). Despite the common belief that later onset breast cancer is more associated with sporadic breast cancer, our data suggest that breast cancer at any age in the family is associated with some increase in the familial risk, though that risk decreases as the age of onset increases. Contralateral and multiple ipsilateral breast cancers might be associated with distinct shared familial risk factors. Our results have implication for genetic counseling and urge gene identification studies.
Literature
1.
go back to reference Evans DG, Lalloo F (2002) Risk assessment and management of high risk familial breast cancer. J Med Genet 39(12):865–871PubMedCrossRef Evans DG, Lalloo F (2002) Risk assessment and management of high risk familial breast cancer. J Med Genet 39(12):865–871PubMedCrossRef
2.
3.
go back to reference Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98(1):61–68PubMedCrossRef Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98(1):61–68PubMedCrossRef
4.
go back to reference Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91PubMedCrossRef Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91PubMedCrossRef
5.
go back to reference Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P (2001) The nation-wide Swedish Family Cancer Database: updated structure and familial rates. Acta Oncol 40(6):772–777PubMedCrossRef Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P (2001) The nation-wide Swedish Family Cancer Database: updated structure and familial rates. Acta Oncol 40(6):772–777PubMedCrossRef
6.
go back to reference The National Board of Health and Welfare CfE (2007) Cancer incidence in Sweden 2006 The National Board of Health and Welfare CfE (2007) Cancer incidence in Sweden 2006
7.
go back to reference Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169–176PubMed Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169–176PubMed
8.
go back to reference Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002PubMedCrossRef Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002PubMedCrossRef
9.
go back to reference Dong C, Hemminki K (2001) Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 92(6):883–887PubMedCrossRef Dong C, Hemminki K (2001) Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 92(6):883–887PubMedCrossRef
10.
go back to reference Dong C, Hemminki K (2001) Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996. Int J Cancer 93(2):155–161PubMedCrossRef Dong C, Hemminki K (2001) Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996. Int J Cancer 93(2):155–161PubMedCrossRef
11.
go back to reference Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ et al (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330–4336PubMedCrossRef Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen XQ, Bowtell D, Trainer AH, Harris M, Lindeman GJ et al (2012) A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 30(35):4330–4336PubMedCrossRef
12.
go back to reference Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404–2410PubMedCrossRef Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M et al (2010) Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol 28(14):2404–2410PubMedCrossRef
13.
go back to reference Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887–5892PubMedCrossRef Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N et al (2009) Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 27(35):5887–5892PubMedCrossRef
14.
go back to reference Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335PubMedCrossRef Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J et al (2004) Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. J Clin Oncol 22(12):2328–2335PubMedCrossRef
15.
go back to reference Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka SN et al (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31(4):433–439PubMedCrossRef Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, Malone KE, Knight JA, Capanu M, Teraoka SN et al (2013) Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women’s Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol 31(4):433–439PubMedCrossRef
16.
go back to reference Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMed Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMed
17.
go back to reference Beckmann KR, Buckingham J, Craft P, Dahlstrom JE, Zhang Y, Roder D, Stuart-Harris R (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158–164PubMedCrossRef Beckmann KR, Buckingham J, Craft P, Dahlstrom JE, Zhang Y, Roder D, Stuart-Harris R (2011) Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort. Breast 20(2):158–164PubMedCrossRef
18.
go back to reference Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937–948PubMed Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937–948PubMed
19.
go back to reference Hemminki K, Ji J, Forsti A (2007) Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res 67(3):868–870PubMedCrossRef Hemminki K, Ji J, Forsti A (2007) Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res 67(3):868–870PubMedCrossRef
20.
go back to reference Ji J, Hemminki K (2007) Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105(2):229–236PubMedCrossRef Ji J, Hemminki K (2007) Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat 105(2):229–236PubMedCrossRef
21.
go back to reference McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624–628PubMedCrossRef McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 321(7261):624–628PubMedCrossRef
22.
go back to reference Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos SI, Ashworth A, Peto J (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366(9496):1554–1557PubMedCrossRef Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos SI, Ashworth A, Peto J (2005) Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study. Lancet 366(9496):1554–1557PubMedCrossRef
23.
go back to reference Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377–382PubMedCrossRef Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P (2005) Genetic implications of bilateral breast cancer: a population based cohort study. Lancet Oncol 6(6):377–382PubMedCrossRef
24.
go back to reference Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A et al (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384–1392PubMedCentralPubMedCrossRef Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A et al (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 104(9):1384–1392PubMedCentralPubMedCrossRef
25.
go back to reference Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mutat Res 473(1):11–21PubMedCrossRef Hemminki K, Mutanen P (2001) Genetic epidemiology of multistage carcinogenesis. Mutat Res 473(1):11–21PubMedCrossRef
26.
go back to reference Li CI, Malone KE, Weiss NS, Daling JR (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 93(13):1008–1013PubMedCrossRef Li CI, Malone KE, Weiss NS, Daling JR (2001) Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst 93(13):1008–1013PubMedCrossRef
27.
go back to reference Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven RM, Hupe P, Hadhri R et al (2012) Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res 18(6):1704–1715PubMedCrossRef Servant N, Bollet MA, Halfwerk H, Bleakley K, Kreike B, Jacob L, Sie D, Kerkhoven RM, Hupe P, Hadhri R et al (2012) Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res 18(6):1704–1715PubMedCrossRef
28.
go back to reference Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886PubMedCrossRef Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879–1886PubMedCrossRef
29.
go back to reference Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception 54(3 Suppl):1S–106S; 1996 Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer. Contraception 54(3 Suppl):1S–106S; 1996
30.
go back to reference Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344–350PubMedCrossRef Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K (2013) Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22(3):344–350PubMedCrossRef
31.
go back to reference Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9(3):221–236PubMedCrossRef Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9(3):221–236PubMedCrossRef
32.
go back to reference Leu M, Reilly M, Czene K (2008) Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst 100(18):1318–1325PubMedCrossRef Leu M, Reilly M, Czene K (2008) Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers. J Natl Cancer Inst 100(18):1318–1325PubMedCrossRef
33.
go back to reference Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27–33PubMedCrossRef Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48(1):27–33PubMedCrossRef
34.
Metadata
Title
Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study
Authors
Elham Kharazmi
Tianhui Chen
Steven Narod
Kristina Sundquist
Kari Hemminki
Publication date
01-02-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2848-3

Other articles of this Issue 1/2014

Breast Cancer Research and Treatment 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine